Intrinsic Value

Outlook Therapeutics, Inc. (OTLK)

$8.19

-0.01 (-0.12%)

Enterprise Value -
Net Debt 12.16
Equity Value -
Shares Outstanding 12.51
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt